dc.contributor
Institut Català de la Salut
dc.contributor
[Majem M] Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain. [Manzano JL] Department of Medical Oncology, H. Germans Trias i Pujol, Catalan Institute of Oncology, ICO-Badalona, Badalona, Spain. [Marquez-Rodas I] Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid, Spain. [Mujika K] Department of Medical Oncology, UGC de Oncología de Gipuzkoa, OSI Donostialdea-Onkologikoa, Guipúzcoa, Spain. [Muñoz-Couselo E] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pérez-Ruiz E] Department of Medical Oncology, Hospital Costa del Sol and UGC Oncol, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Regional Virgen Victoria, Málaga, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Marquez‑Rodas, I.
dc.contributor.author
Mujika, K.
dc.contributor.author
Pérez‑Ruiz, E.
dc.contributor.author
Muñoz Couselo, Eva
dc.contributor.author
Majem Tarruella, Margarita
dc.contributor.author
Manzano, Jose Luis
dc.date.issued
2022-01-25T11:27:29Z
dc.date.issued
2022-01-25T11:27:29Z
dc.identifier
Majem M, Manzano JL, Marquez-Rodas I, Mujika K, Muñoz-Couselo E, Pérez-Ruiz E, et al. SEOM clinical guideline for the management of cutaneous melanoma (2020). Clin Transl Oncol. 2021 May;23:948–960.
dc.identifier
https://hdl.handle.net/11351/6887
dc.identifier
10.1007/s12094-020-02539-9
dc.identifier
000624437100001
dc.description.abstract
Tractament adjuvant; Melanoma; Escenificació
dc.description.abstract
Adjuvant treatment; Melanoma; Staging
dc.description.abstract
Tratamiento adyuvante; Melanoma; Escenificación
dc.description.abstract
Melanoma affects about 6000 patients a year in Spain. A group of medical oncologists from Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines to homogenize the management of these patients. The diagnosis must be histological and determination of BRAF status has to be performed in patients with stage ≥ III. Stage I–III resectable melanomas will be treated surgically. In patients with stage III melanoma, adjuvant treatment with immunotherapy or targeted therapy is also recommended. Patients with unresectable or metastatic melanoma will receive treatment with immunotherapy or targeted therapy, the optimal sequence of these treatments remains unclear. Brain metastases require a separate consideration, since, in addition to systemic treatment, they may require local treatment. Patients must be followed up closely to receive or change treatment as soon as their previous clinical condition changes, since multiple therapeutic options are available.
dc.format
application/pdf
dc.relation
Clinical and Translational Oncology;23
dc.relation
https://doi.org/10.1007/s12094-020-02539-9
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Melanoma - Tractament
dc.subject
Adjuvants immunològics - Ús terapèutic
dc.subject
Medicina clínica - Presa de decisions
dc.subject
DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neuroendocrine Tumors::Melanoma
dc.subject
Other subheadings::Other subheadings::/therapy
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy
dc.subject
PUBLICATION CHARACTERISTICS::Publication Formats::Guideline::Practice Guideline
dc.subject
ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::tumores neuroendocrinos::melanoma
dc.subject
Otros calificadores::Otros calificadores::/terapia
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia
dc.subject
CARACTERÍSTICAS DE PUBLICACIONES::formatos de publicación::guía::guía de práctica clínica
dc.title
SEOM clinical guideline for the management of cutaneous melanoma (2020)
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
